Last updated: 11/07/2018 17:02:48
A phase III, multi-centre, double-blind, parallel group study to compare the efficacy and tolerability of a high dose step-down treatment regimen of fluticasone propionate (2.0mg reducing to 0.5mg daily) with a fixed dose of fluticasone propionate (0.5mg daily) in maintaining the control achieve ...
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A phase III, multi-centre, double-blind, parallel group study to compare the efficacy and tolerability of a high dose step-down treatment regimen of fluticasone propionate (2.0mg reducing to 0.5mg daily) with a fixed dose of fluticasone propionate (0.5mg daily) in maintaining the control achieve ...
Trial description: A phase III, multi-centre, double-blind, parallel group study to compare the efficacy and tolerability of a high dose step-down treatment regimen of fluticasone propionate (2.0mg reducing to 0.5mg daily) with a fixed dose of fluticasone propionate (0.5mg daily) in maintaining the control achieve ...
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Britton MG, Bone MF, Boyd G, Catterall JR, Ward MJ, Richards K. Comparison of a lower fixed dose of inhaled fluticasone propionate (FP) with a high dose step-down regimen of FP in the prevention of re-exacerbations after an acute severe attack of asthma requiring oral corticosteroid therapy. Thorax 1997; 52(Suppl 6) A1.
Medical condition
Asthma
Product
fluticasone propionate
Collaborators
Not applicable
Study date(s)
January 1994 to February 1996
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1996-05-02
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website